Yong Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yong Yin has a total of 221 co-authors. Here are the top co-authors by number of shared publications:
Jing Zhang
Department of Respiratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
21 shared publicationsShuhua Yuan
Department of Respiratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
20 shared publicationsLei Zhang
Department of Respiratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
17 shared publicationsJiande Chen
Department of Respiratory Medicine, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
13 shared publicationsJinhong Wu
Department of Respiratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
10 shared publicationsMingyu Tang
Department of Respiratory Medicine, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
9 shared publications
Latest Publications
- Open Access
- 25 July 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (7) , e70269
Multifocal Sporadic Venous Malformations in a Child Caused by a Novel Somatic Double Mutation of the TEK Gene: A Case Report and Literature Review
Background: Multifocal sporadic venous malformations (MSVM) are a rare and severe subtype of venous malformations (VMs). Although somatic mutations in the TEK gene are frequently implicated in VMs, the clinical and molecular significance of harboring two distinct somatic mutations within a single lesion remains poorly understood. Methods: DNA was extracted from both the lesion and peripheral blood, followed by whole‐exome sequencing (WES) and structural modeling of the TIE2 protein. Results: The proband, a 6‐year‐old Chinese boy, presented at birth with soft‐tissue swelling of the hands and occipital region, which progressively involved the tongue, neck, trunk, extremities, and external genitalia. Imaging demonstrated extensive venous ectasia infiltrating subcutaneous and muscular layers. Despite 20 sessions of sclerotherapy, the lesions continued to progress and showed a strong tendency for recurrence. WES of the lesion revealed two pathogenic somatic mutations in the TEK gene: c.2740C>T (p.L914F) and c.2545C>T (p.R849W), which weren't detected in peripheral blood. Structural modeling suggested no major global conformational changes but showed possible local structural differences within the kinase domain. The double‐mutant variant exhibited predicted enhanced hydrogen bonding at the mutation sites, potentially contributing to local structural rearrangements and altered conformational stability. Conclusion: This report describes a previously unreported case of dual somatic TEK mutations in MSVM. The findings expand the mutational spectrum of TEK ‐related VMs and underscore the importance of lesion‐based genetic testing in complex cases.
- 25 July 2026
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (7) , e70269
Open AccessMultifocal Sporadic Venous Malformations in a Child Caused by a Novel Somatic Double Mutation of the TEK Gene: A Case Report and Literature Review
Background: Multifocal sporadic venous malformations (MSVM) are a rare and severe subtype of venous malformations (VMs). Although somatic mutations in the TEK gene are frequently implicated in VMs, the clinical and molecular significance of harboring two distinct somatic mutations within a single lesion remains poorly understood. Methods: DNA was extracted from both the lesion and peripheral blood, followed by whole‐exome sequencing (WES) and structural modeling of the TIE2 protein. Results: The proband, a 6‐year‐old Chinese boy, presented at birth with soft‐tissue swelling of the hands and occipital region, which progressively involved the tongue, neck, trunk, extremities, and external genitalia. Imaging demonstrated extensive venous ectasia infiltrating subcutaneous and muscular layers. Despite 20 sessions of sclerotherapy, the lesions continued to progress and showed a strong tendency for recurrence. WES of the lesion revealed two pathogenic somatic mutations in the TEK gene: c.2740C>T (p.L914F) and c.2545C>T (p.R849W), which weren't detected in peripheral blood. Structural modeling suggested no major global conformational changes but showed possible local structural differences within the kinase domain. The double‐mutant variant exhibited predicted enhanced hydrogen bonding at the mutation sites, potentially contributing to local structural rearrangements and altered conformational stability. Conclusion: This report describes a previously unreported case of dual somatic TEK mutations in MSVM. The findings expand the mutational spectrum of TEK ‐related VMs and underscore the importance of lesion‐based genetic testing in complex cases.
- 13 June 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (7)
Impact of a multiplex respiratory PCR panel on antibiotic stewardship in hospitalized pediatric pneumonia: a randomized clinical trial
We aimed to evaluate whether the FILMARRAY® Pneumonia Panel (FAPP) added to standard care could effectively guide antibiotic prescriptions in hospitalized pediatric patients with infectious pneumonia. In this single-center, open-label, parallel-group randomized controlled clinical trial, we enrolled hospitalized children (28 days to 18 years old) diagnosed with infectious pneumonia. Participants were randomized to standard care only (control) or to added FAPP (intervention group). The primary outcome was the proportion of patients with antibiotic change within 72 h. Between December 8, 2021, and February 16, 2023, we enrolled 315 patients (157 in the intervention group and 158 in the control group). Pathogens were detected in 86.6% (32.7% bacterial, 56.5% viral, and 10.9% atypical) via FAPP, which may encompass colonizing organisms due to its enhanced sensitivity. The primary outcome was comparable between the intervention and control groups (51.6%, 81/157, versus 49.4%, 78/158; P = 0.693). However, key exploratory secondary outcomes demonstrated significant improvements in the intervention group: total frequency of changes in antibiotic and antiviral agents based on pathogen results (47.8%, 75/157, versus 25.3%, 40/158; P < 0.001) and proportion of patients with antibiotic de-escalation within 72 h (14.6%, 23/157, versus 1.9%, 3/158; P < 0.001). Integrating FILMARRAY® into pediatric pneumonia clinical management did not significantly boost initial overall antibiotic modification rates. However, exploratory analysis showed it improved targeted antimicrobial adjustments and facilitated antibiotic de-escalation, suggesting FILMARRAY® may add value to antibiotic stewardship. Subsequent trials could substantiate this theoretical proposition. Chictr.org.cn, ChiCTR2100047213, registered 11 June 2021-prospectively registered, https://www.chictr.org.cn/showproj.html?proj=128024 . • FILMARRAY® molecular techniques, via semiquantitative analysis to identify potential pathogens, may contribute to reduce antibiotic usage and facilitate more targeted and appropriate antibiotic therapy in adult patients with lower respiratory tract infections. • Integrating FILMARRAY® into pediatric pneumonia care did not notably raise initial overall antibiotic modification rates. However, exploratory analysis showed it improved targeted antimicrobial adjustments and promoted antibiotic de-escalation, suggesting potential value for antibiotic stewardship.
- 13 June 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (7)
Impact of a multiplex respiratory PCR panel on antibiotic stewardship in hospitalized pediatric pneumonia: a randomized clinical trial
We aimed to evaluate whether the FILMARRAY® Pneumonia Panel (FAPP) added to standard care could effectively guide antibiotic prescriptions in hospitalized pediatric patients with infectious pneumonia. In this single-center, open-label, parallel-group randomized controlled clinical trial, we enrolled hospitalized children (28 days to 18 years old) diagnosed with infectious pneumonia. Participants were randomized to standard care only (control) or to added FAPP (intervention group). The primary outcome was the proportion of patients with antibiotic change within 72 h. Between December 8, 2021, and February 16, 2023, we enrolled 315 patients (157 in the intervention group and 158 in the control group). Pathogens were detected in 86.6% (32.7% bacterial, 56.5% viral, and 10.9% atypical) via FAPP, which may encompass colonizing organisms due to its enhanced sensitivity. The primary outcome was comparable between the intervention and control groups (51.6%, 81/157, versus 49.4%, 78/158; P = 0.693). However, key exploratory secondary outcomes demonstrated significant improvements in the intervention group: total frequency of changes in antibiotic and antiviral agents based on pathogen results (47.8%, 75/157, versus 25.3%, 40/158; P < 0.001) and proportion of patients with antibiotic de-escalation within 72 h (14.6%, 23/157, versus 1.9%, 3/158; P < 0.001). Integrating FILMARRAY® into pediatric pneumonia clinical management did not significantly boost initial overall antibiotic modification rates. However, exploratory analysis showed it improved targeted antimicrobial adjustments and facilitated antibiotic de-escalation, suggesting FILMARRAY® may add value to antibiotic stewardship. Subsequent trials could substantiate this theoretical proposition. Chictr.org.cn, ChiCTR2100047213, registered 11 June 2021-prospectively registered, https://www.chictr.org.cn/showproj.html?proj=128024 . • FILMARRAY® molecular techniques, via semiquantitative analysis to identify potential pathogens, may contribute to reduce antibiotic usage and facilitate more targeted and appropriate antibiotic therapy in adult patients with lower respiratory tract infections. • Integrating FILMARRAY® into pediatric pneumonia care did not notably raise initial overall antibiotic modification rates. However, exploratory analysis showed it improved targeted antimicrobial adjustments and promoted antibiotic de-escalation, suggesting potential value for antibiotic stewardship.
- Open Access
- 12 June 2026
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 22 (1)
Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status
Background: Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of type 2 inflammation with potential for personalized asthma management. However, the longitudinal patterns of FeNO and their association with childhood asthma control remain insufficiently characterized. Methods: This cohort study enrolled children with newly diagnosed asthma from Shanghai Children’s Medical Center. Participants underwent baseline assessments and serial FeNO measurements at diagnosis and at 3-month intervals over 12 months. Asthma control was assessed at 12 months using Global Initiative for Asthma (GINA) criteria. Longitudinal trajectories of FeNO were identified using group-based trajectory modeling (GBTM). Associations of time-specific FeNO levels and FeNO trajectory group with uncontrolled asthma at 12 months were analyzed using logistic regression. Results: Among 142 children (mean age 6.92 ± 2.08 years; 71.1% male), 125 (88.0%) achieved controlled asthma and 17 (12.0%) had uncontrolled asthma at 12 months. Elevated FeNO at 3 and 12 months was significantly associated with increased odds of uncontrolled asthma after adjusting for covariates. Longitudinal FeNO levels showed two distinct trajectories: low-stable (80.3% of participants) and high-rising (19.7%). Compared with the low-stable group, the high-rising group had significantly older age, later wheezing onset, higher serum total immunoglobulin E (IgE) and eosinophil percentages (all p < 0.05). Children in the high-rising trajectory group had higher odds of uncontrolled asthma (OR = 5.86; 95% CI: 1.28–29.57; p = 0.025). Conclusions: Elevated FeNO levels during follow-up and a high-rising FeNO trajectory are associated with uncontrolled asthma at 12 months in children with newly diagnosed asthma. Longitudinal FeNO monitoring may help identify children at increased risk of poor asthma control and support more individualized asthma management.
- 12 June 2026
- Published by Springer Nature in Allergy, Asthma & Clinical Immunology
- Vol. 22 (1)
Open AccessLongitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status
Background: Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of type 2 inflammation with potential for personalized asthma management. However, the longitudinal patterns of FeNO and their association with childhood asthma control remain insufficiently characterized. Methods: This cohort study enrolled children with newly diagnosed asthma from Shanghai Children’s Medical Center. Participants underwent baseline assessments and serial FeNO measurements at diagnosis and at 3-month intervals over 12 months. Asthma control was assessed at 12 months using Global Initiative for Asthma (GINA) criteria. Longitudinal trajectories of FeNO were identified using group-based trajectory modeling (GBTM). Associations of time-specific FeNO levels and FeNO trajectory group with uncontrolled asthma at 12 months were analyzed using logistic regression. Results: Among 142 children (mean age 6.92 ± 2.08 years; 71.1% male), 125 (88.0%) achieved controlled asthma and 17 (12.0%) had uncontrolled asthma at 12 months. Elevated FeNO at 3 and 12 months was significantly associated with increased odds of uncontrolled asthma after adjusting for covariates. Longitudinal FeNO levels showed two distinct trajectories: low-stable (80.3% of participants) and high-rising (19.7%). Compared with the low-stable group, the high-rising group had significantly older age, later wheezing onset, higher serum total immunoglobulin E (IgE) and eosinophil percentages (all p < 0.05). Children in the high-rising trajectory group had higher odds of uncontrolled asthma (OR = 5.86; 95% CI: 1.28–29.57; p = 0.025). Conclusions: Elevated FeNO levels during follow-up and a high-rising FeNO trajectory are associated with uncontrolled asthma at 12 months in children with newly diagnosed asthma. Longitudinal FeNO monitoring may help identify children at increased risk of poor asthma control and support more individualized asthma management.
- Open Access
- 3 September 2025
- Published by Frontiers Media SA in Frontiers in Digital Health
- Vol. 7, 1610671
Evaluating large language models in pediatric fever management: a two-layer study
Background: Pediatric fever is a prevalent concern, often causing parental anxiety and frequent medical consultations. While large language models (LLMs) such as ChatGPT, Perplexity, and YouChat show promise in enhancing medical communication and education, their efficacy in addressing complex pediatric fever-related questions remains underexplored, particularly from the perspectives of medical professionals and patients’ relatives.Objective: This study aimed to explore the differences and similarities among four common large language models (ChatGPT3.5, ChatGPT4.0, YouChat, and Perplexity) in answering thirty pediatric fever-related questions and to examine how doctors and pediatric patients’ relatives evaluate the LLM-generated answers based on predefined criteria.Methods: The study selected thirty fever-related pediatric questions answered by the four models. Twenty doctors rated these responses across four dimensions. To conduct the survey among pediatric patients’ relatives, we eliminated certain responses that we deemed to pose safety risks or be misleading. Based on the doctors’ questionnaire, the thirty questions were divided into six groups, each evaluated by twenty pediatric relatives. The Tukey post-hoc test was used to check for significant differences. Some of pediatric relatives was revisited for deeper insights into the results.Results: In the doctors’ questionnaire, ChatGPT3.5 and ChatGPT4.0 outperformed YouChat and Perplexity in all dimensions, with no significant difference between ChatGPT3.5 and ChatGPT4.0 or between YouChat and Perplexity. All models scored significantly better in accuracy than other dimensions. In the pediatric relatives’ questionnaire, no significant differences were found among the models, with revisits revealing some reasons for these results.Conclusions: Internet searches (YouChat and Perplexity) did not improve the ability of large language models to answer medical questions as expected. Patients lacked the ability to understand and analyze model responses due to a lack of professional knowledge and a lack of central points in model answers. When developing large language models for patient use, it's important to highlight the central points of the answers and ensure they are easily understandable.
- 3 September 2025
- Published by Frontiers Media SA in Frontiers in Digital Health
- Vol. 7, 1610671
Open AccessEvaluating large language models in pediatric fever management: a two-layer study
Background: Pediatric fever is a prevalent concern, often causing parental anxiety and frequent medical consultations. While large language models (LLMs) such as ChatGPT, Perplexity, and YouChat show promise in enhancing medical communication and education, their efficacy in addressing complex pediatric fever-related questions remains underexplored, particularly from the perspectives of medical professionals and patients’ relatives.Objective: This study aimed to explore the differences and similarities among four common large language models (ChatGPT3.5, ChatGPT4.0, YouChat, and Perplexity) in answering thirty pediatric fever-related questions and to examine how doctors and pediatric patients’ relatives evaluate the LLM-generated answers based on predefined criteria.Methods: The study selected thirty fever-related pediatric questions answered by the four models. Twenty doctors rated these responses across four dimensions. To conduct the survey among pediatric patients’ relatives, we eliminated certain responses that we deemed to pose safety risks or be misleading. Based on the doctors’ questionnaire, the thirty questions were divided into six groups, each evaluated by twenty pediatric relatives. The Tukey post-hoc test was used to check for significant differences. Some of pediatric relatives was revisited for deeper insights into the results.Results: In the doctors’ questionnaire, ChatGPT3.5 and ChatGPT4.0 outperformed YouChat and Perplexity in all dimensions, with no significant difference between ChatGPT3.5 and ChatGPT4.0 or between YouChat and Perplexity. All models scored significantly better in accuracy than other dimensions. In the pediatric relatives’ questionnaire, no significant differences were found among the models, with revisits revealing some reasons for these results.Conclusions: Internet searches (YouChat and Perplexity) did not improve the ability of large language models to answer medical questions as expected. Patients lacked the ability to understand and analyze model responses due to a lack of professional knowledge and a lack of central points in model answers. When developing large language models for patient use, it's important to highlight the central points of the answers and ensure they are easily understandable.
- Open Access
- 15 August 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 252
Changes in lung function in children after pneumonia: a multicenter study
Background: There are few studies on the changes in lung function after pneumonia in children. This study aims to explore the changes in lung function in children after pneumonia and analyze the risk factors for airway disorder, especially the impact of different pathogen infection on lung function. Methods: This study collected data from patients who were hospitalized due to pneumonia in ten Chinese hospitals between January 2023 and December 2024. Pulmonary function tests were performed to assess changes in lung function one week and one month after discharge. Results: A total of 566 children were included in this study, with 40.6% of patients still showing airway disorder one week after discharge. Different pathogenic infections had varying effects on pulmonary function. MP (Mycoplasma pneumoniae) infection [OR (95%CI): 1.881(1.268–2.789), P = 0.001] and RhV (rhinovirus) infection [OR (95%CI): 2.402(1.027–5.621), P = 0.043] were significant risk factors for the occurrence of SAD (Small Airway Disorder) one week after discharge. Male gender [OR (95%CI): 2.219, P = 0.001] and MP infection [OR (95%CI): 1.681(1.024–2.761), P = 0.039] were significant risk factors for the occurrence of LAD (Large Airway Disorder) one week after discharge. No positive pathogen results [OR (95%CI): 0.366(0.168–0.800), P = 0.011] were significant protective factors for the persistence of SAD one month after discharge, while RhV infection [OR (95%CI): 7.286(0.802, 66.238), P = 0.077] and lung consolidation [OR (95%CI): 1.753(0.956, 3.214), P = 0.069] showed mild significance for the persistence of SAD one month after discharge. Male gender [OR (95%CI): 2.246(1.137–4.436), P = 0.019] and RhV infection [OR (95%CI): 1.967(1.630–237.549), P = 0.019] were significant risk factors for the persistence of LAD one month after discharge, while no positive pathogen results [OR (95%CI): 0.249(0.092–0.678), P = 0.006] were a significant protective factor. Conclusions: Approximately 40.6% of children after pneumonia still had airway disorder one week after discharge, which was closely related to different pathogenic infections. Patients with RhV pneumonia, in particular, should be closely monitored for changes in lung function after discharge.
- 15 August 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 252
Open AccessChanges in lung function in children after pneumonia: a multicenter study
Background: There are few studies on the changes in lung function after pneumonia in children. This study aims to explore the changes in lung function in children after pneumonia and analyze the risk factors for airway disorder, especially the impact of different pathogen infection on lung function. Methods: This study collected data from patients who were hospitalized due to pneumonia in ten Chinese hospitals between January 2023 and December 2024. Pulmonary function tests were performed to assess changes in lung function one week and one month after discharge. Results: A total of 566 children were included in this study, with 40.6% of patients still showing airway disorder one week after discharge. Different pathogenic infections had varying effects on pulmonary function. MP (Mycoplasma pneumoniae) infection [OR (95%CI): 1.881(1.268–2.789), P = 0.001] and RhV (rhinovirus) infection [OR (95%CI): 2.402(1.027–5.621), P = 0.043] were significant risk factors for the occurrence of SAD (Small Airway Disorder) one week after discharge. Male gender [OR (95%CI): 2.219, P = 0.001] and MP infection [OR (95%CI): 1.681(1.024–2.761), P = 0.039] were significant risk factors for the occurrence of LAD (Large Airway Disorder) one week after discharge. No positive pathogen results [OR (95%CI): 0.366(0.168–0.800), P = 0.011] were significant protective factors for the persistence of SAD one month after discharge, while RhV infection [OR (95%CI): 7.286(0.802, 66.238), P = 0.077] and lung consolidation [OR (95%CI): 1.753(0.956, 3.214), P = 0.069] showed mild significance for the persistence of SAD one month after discharge. Male gender [OR (95%CI): 2.246(1.137–4.436), P = 0.019] and RhV infection [OR (95%CI): 1.967(1.630–237.549), P = 0.019] were significant risk factors for the persistence of LAD one month after discharge, while no positive pathogen results [OR (95%CI): 0.249(0.092–0.678), P = 0.006] were a significant protective factor. Conclusions: Approximately 40.6% of children after pneumonia still had airway disorder one week after discharge, which was closely related to different pathogenic infections. Patients with RhV pneumonia, in particular, should be closely monitored for changes in lung function after discharge.
- Top Cited PapersOpen Access
- 23 July 2025
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 12 (1) , e003144
Global, regional and national burden of asthma from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
Background: Asthma represents a significant global health challenge, exhibiting considerable variation in prevalence, incidence, mortality and disability-adjusted life years (DALYs) across regions and countries. This study evaluates global, regional and national trends in asthma burden from 1990 to 2021, analysing associations with temporal, geographical and demographical factors. Methods: Using open data from the Global Burden of Disease (GBD) database (1990–2021), we analysed changes in asthma prevalence, incidence, mortality and DALYs by gender, age and Socio-Demographic Index (SDI) groups. Joinpoint regression analysis calculated the average annual percentage change (AAPC) and annual percentage change (APC). Results: From 1990 to 2021, the age-standardised prevalence and incidence rates of asthma declined by 40.01% and 29.89%, respectively. While asthma deaths increased slightly, the age-standardised mortality rate (ASMR) declined by 46.01%. The highest prevalence was observed in South Asia, East Asia and high-income North America, while low-SDI regions exhibited elevated mortality and DALYs. The age and sex-specific patterns indicated a higher asthma burden among females. The results of the joinpoint analysis indicated a global age-standardised incidence rate increase between 2005 and 2010 for both males and females. The ASMR exhibited a statistically significant decline from 1990 to 2021. Conclusions: The global age-standardised rate of asthma burden declined from 1990 to 2021. However, asthma remains a significant public health issue, particularly in regions with lower socioeconomic development. Understanding global and regional trends in asthma can inform future policies and interventions, aiming to promote more equitable prevention, diagnosis and treatment worldwide.
- 23 July 2025
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 12 (1) , e003144
Top Cited PapersOpen AccessGlobal, regional and national burden of asthma from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
Background: Asthma represents a significant global health challenge, exhibiting considerable variation in prevalence, incidence, mortality and disability-adjusted life years (DALYs) across regions and countries. This study evaluates global, regional and national trends in asthma burden from 1990 to 2021, analysing associations with temporal, geographical and demographical factors. Methods: Using open data from the Global Burden of Disease (GBD) database (1990–2021), we analysed changes in asthma prevalence, incidence, mortality and DALYs by gender, age and Socio-Demographic Index (SDI) groups. Joinpoint regression analysis calculated the average annual percentage change (AAPC) and annual percentage change (APC). Results: From 1990 to 2021, the age-standardised prevalence and incidence rates of asthma declined by 40.01% and 29.89%, respectively. While asthma deaths increased slightly, the age-standardised mortality rate (ASMR) declined by 46.01%. The highest prevalence was observed in South Asia, East Asia and high-income North America, while low-SDI regions exhibited elevated mortality and DALYs. The age and sex-specific patterns indicated a higher asthma burden among females. The results of the joinpoint analysis indicated a global age-standardised incidence rate increase between 2005 and 2010 for both males and females. The ASMR exhibited a statistically significant decline from 1990 to 2021. Conclusions: The global age-standardised rate of asthma burden declined from 1990 to 2021. However, asthma remains a significant public health issue, particularly in regions with lower socioeconomic development. Understanding global and regional trends in asthma can inform future policies and interventions, aiming to promote more equitable prevention, diagnosis and treatment worldwide.
- Open Access
- 3 July 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1519751
Enhancing pediatric asthma management in underdeveloped regions through ChatGPT training for doctors: a randomized controlled trial
Background: Childhood asthma represents a significant challenge globally, especially in underdeveloped regions. Recent advancements in Large Language Models (LLMs), such as ChatGPT, offer promising improvements in medical service quality.Methods: This randomized controlled trial assessed the effectiveness of ChatGPT in enhancing physicians' childhood asthma management skills. A total of 192 doctors from varied healthcare environments in China were divided into a control group, receiving traditional medical literature training, and an intervention group, trained in utilizing ChatGPT. Assessments conducted before and after training, and a 2-week follow-up, measured the training's impact.Results: The intervention group showed significant improvement, with scores of test questions increasing by approximately 20 out of 100 (improving to 72 ± 8 from a baseline, vs. the control group's increase to 50 ± 9). Post-training, ChatGPT's regular usage among the intervention group jumped from 6.3% to 62%, markedly above the control group's 4.3%. Moreover, physicians in the intervention group reported higher levels of familiarity, effectiveness, satisfaction, and intention for future use of ChatGPT.Conclusion: ChatGPT training significantly improves childhood asthma management among physicians in underdeveloped regions. This underscores the utility of LLMs like ChatGPT as effective educational tools in medical training, highlighting the need for further research into their integration and patient outcome impacts.
- 3 July 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1519751
Open AccessEnhancing pediatric asthma management in underdeveloped regions through ChatGPT training for doctors: a randomized controlled trial
Background: Childhood asthma represents a significant challenge globally, especially in underdeveloped regions. Recent advancements in Large Language Models (LLMs), such as ChatGPT, offer promising improvements in medical service quality.Methods: This randomized controlled trial assessed the effectiveness of ChatGPT in enhancing physicians' childhood asthma management skills. A total of 192 doctors from varied healthcare environments in China were divided into a control group, receiving traditional medical literature training, and an intervention group, trained in utilizing ChatGPT. Assessments conducted before and after training, and a 2-week follow-up, measured the training's impact.Results: The intervention group showed significant improvement, with scores of test questions increasing by approximately 20 out of 100 (improving to 72 ± 8 from a baseline, vs. the control group's increase to 50 ± 9). Post-training, ChatGPT's regular usage among the intervention group jumped from 6.3% to 62%, markedly above the control group's 4.3%. Moreover, physicians in the intervention group reported higher levels of familiarity, effectiveness, satisfaction, and intention for future use of ChatGPT.Conclusion: ChatGPT training significantly improves childhood asthma management among physicians in underdeveloped regions. This underscores the utility of LLMs like ChatGPT as effective educational tools in medical training, highlighting the need for further research into their integration and patient outcome impacts.
- Open Access
- 8 August 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1385600
Imaging features and clinical evaluation of pulmonary nodules in children
Background: With the widespread use of computed tomography (CT), the detection rate of pulmonary nodules in children has gradually increased. Due to the lack of epidemiological evidence and clinical guideline on pulmonary nodule treatment in children, we aimed to provide a reference for the clinical diagnosis and management of pediatirc pulmonary nodules.Methods: This retrospective study collected consecutive cases from April 2012 to July 2021 in the Shanghai Children’s Medical Center. The sample included children with pulmonary nodules on chest CT scans and met the inclusion criteria. All patients were categorized into tumor and non-tumor groups by pre-CT clinical diagnosis. Nodule characteristics between groups were analyzed. To establish a clinical assessment model for the benign versus malignant pulmonary nodules, patients who have been followed-up for three months were detected and a decision tree model for nodule malignancy prediction was constructed and validated.Results: The sample comprised 1341 patients with an average age of 7.2 ± 4.6 years. More than half of them (51.7%) were diagnosed with malignancies before CT scan. 48.3% were diagnosed with non-tumor diseases or healthy. Compared to non-tumor group, children with tumor were more likely to have multiple nodules in both lungs, with larger size and often be accompanied by osteolytic or mass lesions. Based on the decision tree model, patients’ history of malignancies, nodules diameter size≥5mm, and specific nodule distribution (multiple in both lungs, multiple in the right lung or solitary in the upper or middle right lobe) were important potential predictors for malignity. In the validation set, sensitivity, specificity and AUC were 0.855, 0.833 and 0.828 (95%CI: 0.712-0.909), respectively.Conclusion: This study conducted a clinical assessment model to differentiate benignity and malignancy of pediatric pulmonary nodules. We suggested that a nodule’s diameter, distribution and patient’s history of malignancies are predictable factors in benign or malignant determination.
- 8 August 2024
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 14, 1385600
Open AccessImaging features and clinical evaluation of pulmonary nodules in children
Background: With the widespread use of computed tomography (CT), the detection rate of pulmonary nodules in children has gradually increased. Due to the lack of epidemiological evidence and clinical guideline on pulmonary nodule treatment in children, we aimed to provide a reference for the clinical diagnosis and management of pediatirc pulmonary nodules.Methods: This retrospective study collected consecutive cases from April 2012 to July 2021 in the Shanghai Children’s Medical Center. The sample included children with pulmonary nodules on chest CT scans and met the inclusion criteria. All patients were categorized into tumor and non-tumor groups by pre-CT clinical diagnosis. Nodule characteristics between groups were analyzed. To establish a clinical assessment model for the benign versus malignant pulmonary nodules, patients who have been followed-up for three months were detected and a decision tree model for nodule malignancy prediction was constructed and validated.Results: The sample comprised 1341 patients with an average age of 7.2 ± 4.6 years. More than half of them (51.7%) were diagnosed with malignancies before CT scan. 48.3% were diagnosed with non-tumor diseases or healthy. Compared to non-tumor group, children with tumor were more likely to have multiple nodules in both lungs, with larger size and often be accompanied by osteolytic or mass lesions. Based on the decision tree model, patients’ history of malignancies, nodules diameter size≥5mm, and specific nodule distribution (multiple in both lungs, multiple in the right lung or solitary in the upper or middle right lobe) were important potential predictors for malignity. In the validation set, sensitivity, specificity and AUC were 0.855, 0.833 and 0.828 (95%CI: 0.712-0.909), respectively.Conclusion: This study conducted a clinical assessment model to differentiate benignity and malignancy of pediatric pulmonary nodules. We suggested that a nodule’s diameter, distribution and patient’s history of malignancies are predictable factors in benign or malignant determination.
- Open Access
- 6 August 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1365587
Association of obesity with osteoporotic fracture risk in individuals with bone metabolism-related conditions: a cross sectional analysis
Introduction: This study aimed to investigate the individual and composite associations of different indices of obesity on osteoporotic fractures at three different sites among individuals affected by conditions influencing bone metabolism.Methods: Participants were included from the National Health and Nutrition Examination Survey (NHANES), a national cross-sectional survey. BMI and WC were used separately and in combination to evaluate the presence of obesity. Obesity was defined as BMI ≥ 30 kg/m2, WC ≥ 88 cm in females, and WC ≥ 102 cm in males. Associations between obesity and osteoporotic fractures were assessed using multivariable logistic regression and OR curves. Associations modified by age, sex, race, and alcohol consumption were also evaluated.Results: A total of 5377 participants were included in this study. In multivariable logistic regression analyses, we found that BMI, WC, BMI defining obesity, and WC defining obesity were negatively associated with hip fracture (all p < 0.05). However, harmful associations between WC and BMI defining obesity and spine fracture were found (all p < 0.05). OR curves revealed that BMI and WC had a linear relationship with hip and spine fractures (all P for non-linearity >0.05). Further analyses showed that the highest WC quartile was harmfully associated with a higher risk of spine fractures (p < 0.05). Obese participants diagnosed by both BMI and WC were less likely to have hip fractures but more likely to have spine fractures (all P for trend <0.05). A significant interaction between age (Ref: age < 50 years) and BMI and WC was detected for hip fractures (all P for interaction <0.05).Discussion: In people with conditions influencing bone metabolism, obesity diagnosed by BMI and WC was associated with a lower risk of hip fracture, while obesity diagnosed by BMI and the highest WC quartile were associated with a higher risk of spine fracture.
- 6 August 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1365587
Open AccessAssociation of obesity with osteoporotic fracture risk in individuals with bone metabolism-related conditions: a cross sectional analysis
Introduction: This study aimed to investigate the individual and composite associations of different indices of obesity on osteoporotic fractures at three different sites among individuals affected by conditions influencing bone metabolism.Methods: Participants were included from the National Health and Nutrition Examination Survey (NHANES), a national cross-sectional survey. BMI and WC were used separately and in combination to evaluate the presence of obesity. Obesity was defined as BMI ≥ 30 kg/m2, WC ≥ 88 cm in females, and WC ≥ 102 cm in males. Associations between obesity and osteoporotic fractures were assessed using multivariable logistic regression and OR curves. Associations modified by age, sex, race, and alcohol consumption were also evaluated.Results: A total of 5377 participants were included in this study. In multivariable logistic regression analyses, we found that BMI, WC, BMI defining obesity, and WC defining obesity were negatively associated with hip fracture (all p < 0.05). However, harmful associations between WC and BMI defining obesity and spine fracture were found (all p < 0.05). OR curves revealed that BMI and WC had a linear relationship with hip and spine fractures (all P for non-linearity >0.05). Further analyses showed that the highest WC quartile was harmfully associated with a higher risk of spine fractures (p < 0.05). Obese participants diagnosed by both BMI and WC were less likely to have hip fractures but more likely to have spine fractures (all P for trend <0.05). A significant interaction between age (Ref: age < 50 years) and BMI and WC was detected for hip fractures (all P for interaction <0.05).Discussion: In people with conditions influencing bone metabolism, obesity diagnosed by BMI and WC was associated with a lower risk of hip fracture, while obesity diagnosed by BMI and the highest WC quartile were associated with a higher risk of spine fracture.
- Open Access
- 17 May 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1362119
The correlation between selenium intake and lung function in asthmatic people: a cross-sectional study
Objective: This study aimed to examine the correlation between selenium intake and lung function in asthmatic people.Methods: A total of 4,541 individuals in the US National Health and Nutrition Examination Survey (NHANES) were included in this study. Multivariate linear regression, variance inflation factor, restricted cubic splines and quantile regression were used to analyze the relationship between Se intake and lung function. We divided selenium intake into four levels based on quartiles: Q1: Se ≤ 76.75 mcg/d; Q2: 76.75–105.1 mcg/d; Q3: 105.1–137.65 mcg/d; and Q4: Se ≥137.65 mcg/d.Results: Asthma was negatively associated with the Ratio of Forced Expiratory Volume 1st Second to Forced Vital Capacity (FEV1/FVC) (β = −0.04, 95% CI: −0.06 to −0.02) and FEV1 (β = −215, 95% CI: −340 to −90). Se intake was positively associated with Forced Expiratory Volume 1st Second (FEV1) (β =3.30 95% CI: 2.60 to 4.00) and Forced Vital Capacity (FVC) (β =4.30, 95% CI: 3.50 to 5.10). In asthmatic individuals, the positive effects of Se intake on FVC were enhanced with increasing Se intake, while the positive effects of Se intake on FEV1 varied less dramatically. High Se intake (Q4 level, above 137.65 mcg/d) improved FVC (β = 353, 95% CI: 80 to 626) and FEV1 (β = 543, 95% CI: 118 to 969) in asthmatic patients compared to low Se intake (Q1 level, below 76.75 mcg/d). At the Q2 level (76.75–105.1 mcg/d) and Q4 level (Se ≥137.65 mcg/d) of Se intake, the correlation between FEV1 and asthma disappeared.Conclusion: Our research has revealed a positive correlation between selenium intake and lung function in asthma patients and the strength of this positive correlation is related to the amount of selenium intake. We recommend that asthma patients consume 137.65 mcg to 200 mcg of selenium daily to improve pulmonary function while avoiding the adverse effects of selenium on the human body.
- 17 May 2024
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 11, 1362119
Open AccessThe correlation between selenium intake and lung function in asthmatic people: a cross-sectional study
Objective: This study aimed to examine the correlation between selenium intake and lung function in asthmatic people.Methods: A total of 4,541 individuals in the US National Health and Nutrition Examination Survey (NHANES) were included in this study. Multivariate linear regression, variance inflation factor, restricted cubic splines and quantile regression were used to analyze the relationship between Se intake and lung function. We divided selenium intake into four levels based on quartiles: Q1: Se ≤ 76.75 mcg/d; Q2: 76.75–105.1 mcg/d; Q3: 105.1–137.65 mcg/d; and Q4: Se ≥137.65 mcg/d.Results: Asthma was negatively associated with the Ratio of Forced Expiratory Volume 1st Second to Forced Vital Capacity (FEV1/FVC) (β = −0.04, 95% CI: −0.06 to −0.02) and FEV1 (β = −215, 95% CI: −340 to −90). Se intake was positively associated with Forced Expiratory Volume 1st Second (FEV1) (β =3.30 95% CI: 2.60 to 4.00) and Forced Vital Capacity (FVC) (β =4.30, 95% CI: 3.50 to 5.10). In asthmatic individuals, the positive effects of Se intake on FVC were enhanced with increasing Se intake, while the positive effects of Se intake on FEV1 varied less dramatically. High Se intake (Q4 level, above 137.65 mcg/d) improved FVC (β = 353, 95% CI: 80 to 626) and FEV1 (β = 543, 95% CI: 118 to 969) in asthmatic patients compared to low Se intake (Q1 level, below 76.75 mcg/d). At the Q2 level (76.75–105.1 mcg/d) and Q4 level (Se ≥137.65 mcg/d) of Se intake, the correlation between FEV1 and asthma disappeared.Conclusion: Our research has revealed a positive correlation between selenium intake and lung function in asthma patients and the strength of this positive correlation is related to the amount of selenium intake. We recommend that asthma patients consume 137.65 mcg to 200 mcg of selenium daily to improve pulmonary function while avoiding the adverse effects of selenium on the human body.